UDG Healthcare Public Limited Co. Formalises Joint Venture with CMIC in Japan
October 01 2014 - 2:00AM
RNS Non-Regulatory
TIDMUDG
UDG Healthcare Public Limited Co.
01 October 2014
UDG Healthcare formalises Joint Venture with
CMIC in Japan
1(st) October 2014: UDG Healthcare plc ("the Group"), a leading
international provider of healthcare services, announces that it
has formalised its existing partnership with CMIC by creating a new
Joint Venture ("JV") company to fully service the Japanese contract
sales organisation ("CSO") market. This agreement formalises the
existing successful partnership with CMIC, which began in 2012 and
the new JV which will be called CMIC Ashfield will provide a
platform for future growth within the Japanese market.
Background
-- UDG Healthcare will acquire a 49.9% stake in CMIC MPSS ("CMIC), from CMIC Holdings.
-- CMIC MPSS & Ashfield Japan have been working in
partnership since Autumn 2012 and have developed a proposition that
combines the experience and expertise of one of the leading
international CSOs with the local knowledge, together with the
capability of one of Japan's leading CSOs.
-- By leveraging the expertise of both businesses, CMIC Ashfield
aims to change the direction of the CSO market in Japan by
providing flexible, tailor-made, value-added and evidence-based
solutions.
-- The existing partnership has been very successful to date,
achieving strong growth and reaching profitability ahead of
schedule in H1 2014.
-- The Joint Venture further strengthens UDG Healthcare's CSO
business in Japan, and is in line with the group's overall strategy
of expansion in growth markets.
Commenting on the announcement, Liam FitzGerald, Chief Executive
of UDG Healthcare said:
"Our partnership with CMIC in the Japanese market has already
delivered excellent results and has far exceeded our initial
expectations. CMIC is well established in the Japanese market and
will further strengthen UDG Healthcare's presence in the second
largest global pharmaceutical market. With our combined resources
and expertise, we look forward to fully developing a market leading
contract sales business in Japan providing evidence-based solutions
for the healthcare industry."
ENDS
For reference:
Investors and Analysts:
Alan Ralph David Marshall
CFO Head of Investor Relations
UDG Healthcare plc UDG Healthcare plc
Tel: +353-1-463-2300 Tel: + 353-1-463-2300
Media:
Greg Lawless / Lisa Kavanagh
Powerscourt
Tel: +44-207-250-1446
About UDG Healthcare plc:
Listed on the London Stock Exchange, UDG Healthcare plc is a
leading international provider of services to healthcare
manufacturers and pharmacies, with operations in 22 countries
including the US, UK, Ireland and Germany.
UDG Healthcare plc operates across three divisions: Ashfield
Commercial and Medical Services, Supply Chain Services and Sharp
Packaging Services.
Ashfield Commercial and Medical Services is a global leader in
the provision of contract sales outsourcing services to
pharmaceutical manufacturers with operations in major markets
including continental Europe, the UK, North America and a presence
in South America and Asia. The division provides sales teams,
telesales, nurse educators, medical information, healthcare
communications and event management services to healthcare
companies in 22 countries. It focuses on supporting healthcare
professionals and patients at all stages of the product life
cycle.
Supply Chain Services includes the United Drug Supply Chain
Services and the Aquilant Specialist Healthcare Services
businesses. United Drug Supply Chain Services is the largest
pharmaceutical wholesaler on the island of Ireland, providing
logistics services to healthcare companies, pharmacies and
hospitals. It is also the leading pre-wholesaler in Ireland.
Aquilant Specialist Healthcare Services is a leading provider of
outsourced sales, marketing, distribution and engineering services
to the medical and scientific sectors in Ireland and the UK.
Sharp Packaging Services is a leading international provider of
pharmaceutical contract packaging and clinical trials materials
services with facilities in the US, UK, Dutch and Belgian
markets.
For more information go to: www.udghealthcare.com
About CMIC HOLDINGS Co., Ltd.
The CMIC Group provides services to support mainly the
development and also the manufacturing, sales and marketing of
pharmaceutical products, health information to general consumers,
develop our own diagnostics and orphan drugs, and a comprehensive
range of other services.
For details, please visit http://www.cmic-holdings.co.jp/e/
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAURSORSVAKOAR
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024